DST has identified the chances in developing, manufacturing and marketing in vitro tests for point of care diagnostics. Major products of the company are tests based on the FastCheckPOC® platform that require only little amounts of capillary or heparin blood. These tests come as complete kits and do not require any further equipment or readers. The test result becomes visible as an unambiguous patented display after max. 30 minutes. DST’s FastCheckPOC® allergy tests screen specific IgE against multiple airborne or food allergens, respectively and covers 90% of the relevant European allergies.